At a Glance: Monkeypox in Virginia

Number of Monkeypox Cases (as of August 8, 2022)

Virginia total


For healthcare providers, please visit VDH’s Monkeypox website for Healthcare Providers

Virginia 2022 Outbreak Data

Monkeypox Cases by Region*

Monkeypox Cases by Age Group*

Monkeypox Cases by Race and Ethnicity*

Monkeypox Cases by Sex*

*Data as of August 8, 2022. The Virginia Department of Health updates these data by 10 a.m. on business days based on data entered by 5 p.m. the prior day. All data are preliminary and subject to change based on additional reporting. Cases include confirmed (monkeypox) and probable (orthopoxvirus) cases using the CDC Case Definition, adopted July 12, 2022. To protect patient confidentiality, VDH will provide cases by region, not by health district, until five or more cases are identified in each district

Vaccine and Treatment Information

What is VDH doing to get monkeypox treatment to those who need it?

VDH aims to ensure equitable access to vaccines and treatment for Monkeypox. To date, the VDH Central Pharmacy has ordered a small supply of tecovirimat (TPOXX), an antiviral recommended for people who are more likely to get severely ill, including patients with weakened immune systems

VDH is working with healthcare providers to ensure they have information about monkeypox treatment and will work with healthcare providers who request the medication for their patients. 

VDH has been able to fulfill all requests that have been received to date. Should demand increase, VDH will request additional doses from the CDC to deploy on an as-needed basis. 

VDH Health Department Locator Tool 

What vaccines are currently available in the United States?

Two vaccines, JYNNEOS and ACAM2000, are available in the United States to prevent monkeypox. Monkeypox vaccines are recommended only for individuals at high risk of exposure. 

Both vaccines can be used for Post-Exposure Prophylaxis (PEP), Expanded PEP, and Pre-Exposure Prophylaxis (PrEP). 

In the US, there is currently a limited supply of JYNNEOS, although more is expected in the coming weeks and months. There is an ample supply of ACAM2000 available from the CDC; however, this vaccine has some risks and concerns when given to people with certain health conditions like a weakened immune system, some skin conditions, and pregnancy. ACAM2000 is not currently available in Virginia for those reasons.

For more information on monkeypox vaccines, visit CDC Considerations for Monkeypox Vaccination.

What vaccines are currently available in Virginia?

Virginia is currently utilizing JYNNEOS as the vaccine of choice, so long as supply allows. Virginia continues to order and receive JYNNEOS supply from the federal government.

Vaccine is available in areas that have had at least one monkeypox case and that have a high prevalence of high risk populations. 

VDH is working to provide vaccine access to Virginians who have been exposed or are at high risk of being exposed to monkeypox.  

Individuals who are known to be exposed to monkeypox or are at high risk for being exposed are being contacted by their local health department through case investigations. Currently, local health departments are working through existing networks to identify those who are eligible for the vaccine to offer vaccine appointments to ensure prompt distribution of the vaccine to the most vulnerable in Virginia.

More information about accessing the vaccine will be available on this website as more supply becomes available.

Last updated: August 8, 2022

Opens pdf to download

Opens document to download

Opens in a new window

External link will open in a new window.  Click link to exit Virginia Department of Health Website.